Clinical Trial Update: Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin [Phase 2]

View source ↗

Summary

A Phase 2 study comparing the investigational PF-04937319 to glimepiride in adults with type 2 diabetes on metformin completed, with results posted in 2017 to e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glimepiride (glimepiride)
• PF-04937319

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2017-01-31